Why This Circular Matters
The National Stock Exchange of India, vide Circular No. NSE/SME/73818 dated April 20, 2026, revised the methodology for computing Free Cash Flow to Equity applicable to issuers seeking to list on the NSE Emerge platform.
The change is effective immediately for all Draft Red Herring Prospectuses filed on NSE Emerge from April 20, 2026.
If your company is in the IPO preparation pipeline, everything about how FCFE is calculated has changed. If you were previously failing the FCFE test, you may now pass. If you were structuring your pre-IPO capital raises without considering FCFE, that calculus is now different.
What FCFE Is and Why NSE Uses It
Free Cash Flow to Equity measures the cash available to equity shareholders after the company has met all its operating expenses, paid taxes, made capital expenditures, and handled its debt obligations. It is a more demanding test than profitability because it captures real cash flow, not accounting profit.
NSE introduced FCFE as an eligibility criterion effective September 1, 2024, requiring SMEs to demonstrate positive FCFE for at least two out of the three financial years preceding the date of filing the DRHP.
The logic was sound. The SME platform had seen companies with reported profits but poor cash generation. FCFE was intended to filter out companies whose earnings did not translate into real cash available to shareholders.
The Problem With the Original Formula
The original formula was:
FCFE = Cash Flow from Operations – Purchase of Fixed Assets + Net Borrowings – Interest × (1 – Tax Rate)
The issue was that the earlier formula captured operating cash flows, capital expenditure, borrowings, and interest costs, but did not factor in proceeds from equity capital raised by the company. As a result, for growth-stage SMEs in an expansion phase, there could be a mismatch between the FCFE outcome and the company’s actual funding profile. Despite receiving substantial investor capital, such companies could fail the FCFE threshold where operating cash flows remained subdued due to ongoing growth and scale-up activities.
A company that had raised Rs. 5 crore from angel investors and was deploying that into capex and working capital could show negative FCFE even though it was in a healthy financial position. The formula was penalising exactly the kind of growth-oriented SME the platform was designed for.
The Revised Formula: April 2026
The new formula is: FCFE = Cash Flow from Operations – Purchase of Fixed Assets + Proceeds from Issuance of Capital + Net Borrowings – Interest × (1 – t)
The single addition is Proceeds from Issuance of Capital. This brings within the FCFE construct all cash inflows arising from fresh equity capital raised during the relevant financial year.
Defining Each Component
Cash Flow from Operations
Net cash flow from operations means net cash from operating activities minus income tax paid, as per the audited cash flow statement.
This is taken directly from the Statement of Cash Flows in the audited financials. Income tax paid in the year is deducted from the operating cash flow line, not calculated separately.
Purchase of Fixed Assets
Fixed assets for FCFE computation include both tangible and intangible assets.
This means software, patents, and other intangible purchases are included in the capex deduction, not just property, plant, and equipment. Companies with significant software development costs capitalised as intangibles need to account for this.
Proceeds from Issuance of Capital
This new component includes equity share capital, preference share capital, and securities premium, where received in cash, as an explicit positive component in the computation of FCFE.
The cash qualification matters. Non-cash capital transactions, such as shares issued as consideration for an acquisition, do not count. Only actual cash inflows from capital issuances are included.
Hybrid securities such as convertible preference stocks and debentures shall be categorised depending on how they are treated in the restated financial statements.
If a convertible instrument is treated as debt in the restated financials, it flows through the net borrowings line, not the proceeds from issuance of capital line. Classification must follow the restated financial statement treatment, not the legal form of the instrument.
Net Borrowings
Net borrowings equal proceeds from long-term borrowings minus repayments, plus proceeds from short-term borrowings minus repayments.
This is a net figure. A company that borrowed Rs. 3 crore and repaid Rs. 1 crore shows net borrowings of Rs. 2 crore. A company that made no new borrowings but repaid Rs. 2 crore shows net borrowings of negative Rs. 2 crore.
The NBFC Exception
For non-banking financial companies, where short-term borrowings and interest flow through operating cash flows rather than financing activities, net borrowings for the FCFE calculation will comprise only long-term borrowings, to avoid double-counting.
For an NBFC, including short-term borrowings in net borrowings when those borrowings are already reflected in operating cash flows would result in counting the same cash flow twice. The circular addresses this by limiting the net borrowings component to long-term borrowings only for NBFCs.
Interest
For financial costs, only interest on borrowings will be considered. Other charges like bank fees, penalties, and statutory dues are excluded.
Processing fees, prepayment charges, and similar financing costs do not enter the FCFE calculation. Only the interest line on borrowings is used.
The Tax Rate
The effective tax rate is calculated as 1 minus PAT divided by PBT, derived from the restated financial statements. The interest deduction is tax-adjusted to reflect the fact that interest is tax-deductible.
Consolidated vs Standalone
If a company has subsidiaries, the FCFE needs to be computed on a consolidated basis wherever appropriate.
Companies with material subsidiaries cannot present standalone FCFE figures that exclude subsidiary cash flows. The FCFE test applies to the consolidated entity.
Practical Implications of the Change
Companies That Now Qualify
Issuers which may earlier have fallen short of the FCFE threshold despite having received genuine cash equity support may now qualify under the revised computation. This is likely to be particularly relevant for growth-stage SMEs with constrained operating cash flows but meaningful capital infusions during the relevant period.
A company that raised Rs. 4 crore in a pre-IPO round in FY24, showed negative operating cash flow of Rs. 1.5 crore in that year, had net borrowings of Rs. 0.5 crore, made Rs. 1 crore in capex, and paid Rs. 0.3 crore in post-tax interest would have shown negative FCFE of Rs. 2.3 crore under the old formula. Under the new formula, adding Rs. 4 crore from the capital raise produces positive FCFE of Rs. 1.7 crore for that year.
Pre-IPO Structuring Is Now Directly Linked to Eligibility
From a deal execution standpoint, this changes the playbook. Pre-IPO capital raises, timing of infusions, and instrument classification are now directly linked to eligibility. FCFE is no longer merely a backward-looking eligibility metric; it now has a direct bearing on pre-IPO structuring decisions.
A company planning a pre-IPO round needs to consider not just the valuation and dilution but which of the three preceding financial years the capital infusion falls into, and how it affects the two-out-of-three FCFE test.
The Honest Caution
A key concern is that companies with weaker operational cash flow but strong fundraising abilities might now qualify. This could increase the number of listed companies whose long-term survival relies more on ongoing capital infusions than robust self-generated cash flow.
The revised formula is more generous to growth-stage companies. It is also more forgiving to companies that have not yet demonstrated operational cash generation. Investors on the NSE Emerge platform should be aware that a positive FCFE under the revised formula does not necessarily mean the business generates cash from its operations independently.
Lorvet Advisory Services advises SMEs on FCFE computation, pre-IPO structuring, and NSE Emerge eligibility assessment under the revised April 2026 framework. The interaction between capital raise timing, instrument classification, and FCFE outcomes requires careful analysis well before the DRHP filing timeline. Companies that run this analysis early avoid the scenario where a structuring decision made for other reasons inadvertently fails the FCFE test in a critical year.
FAQs
Does the April 2026 circular apply to DRHPs already in progress?
The amendment is effective immediately and applies to all DRHPs filed on NSE Emerge on or after April 20, 2026. DRHPs filed before April 20, 2026, use the earlier formula.
Does a pre-IPO round always improve FCFE?
Only if it is structured as equity or preference shares and the cash is received in the financial year being tested. Non-cash transactions and instruments classified as debt in the restated financials do not count as proceeds from issuance of capital.
Does BSE SME require FCFE compliance?
No. The FCFE requirement is specific to NSE Emerge. Companies applying to BSE SME are not subject to the FCFE test.
What if the company has no external capital raises in any of the three years?
Then the April 2026 change makes no difference. The FCFE calculation for that company is identical to the pre-April formula. The change only benefits companies that raised equity or preference capital.
How are convertible notes treated in the FCFE calculation?
Classification follows how the instrument is treated in the restated financial statements. If treated as debt, it goes through net borrowings. If treated as equity, it goes through proceeds from issuance of capital. The legal form of the instrument does not govern the classification.
Can FCFE be negative in one year and still qualify?
Yes. The requirement is positive FCFE in at least two out of three years. One negative year is acceptable as long as the other two are positive.
